Investor Presentaiton

Assessments There are two primary assessments for the Drug Price Transparency program: 1. Annual assessment paid by all prescription drug manufacturers and 2. Reporting assessment paid by prescription drug manufacturers who file a report(s) during the current reporting year Billing for all assessments will occur by October 1st each year. 33

View entire presentation